Prashant Mehta

810 total citations
35 papers, 582 citations indexed

About

Prashant Mehta is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Prashant Mehta has authored 35 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in Prashant Mehta's work include Chronic Lymphocytic Leukemia Research (5 papers), Cancer Genomics and Diagnostics (4 papers) and COVID-19 and healthcare impacts (4 papers). Prashant Mehta is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Cancer Genomics and Diagnostics (4 papers) and COVID-19 and healthcare impacts (4 papers). Prashant Mehta collaborates with scholars based in India, United States and United Kingdom. Prashant Mehta's co-authors include Giampietro Schiavo, Cesare Montecucco, Michael C. Wilson, Annalisa Santucci, Fabio Benfenati, Bibhuti R. DasGupta, Jacob Raber, Loren H. Parsons, Max Kreifeldt and Floyd E. Bloom and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Prashant Mehta

30 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Mehta India 8 269 177 175 160 79 35 582
Marina Siebert Brazil 14 109 0.4× 118 0.7× 146 0.8× 134 0.8× 36 0.5× 51 581
Patricia Dill Switzerland 14 87 0.3× 65 0.4× 238 1.4× 135 0.8× 97 1.2× 29 728
Carlos Casasnovas Spain 14 179 0.7× 149 0.8× 270 1.5× 60 0.4× 57 0.7× 40 567
Mark Wardle United Kingdom 15 359 1.3× 189 1.1× 177 1.0× 22 0.1× 124 1.6× 35 972
Kazutaka Sumita Japan 14 69 0.3× 108 0.6× 274 1.6× 129 0.8× 54 0.7× 48 561
Mateus Mistieri Simabukuro Brazil 13 673 2.5× 132 0.7× 128 0.7× 50 0.3× 77 1.0× 27 795
Raymond T. Ferri United States 7 88 0.3× 103 0.6× 147 0.8× 116 0.7× 27 0.3× 8 628
Marie Hully France 11 85 0.3× 106 0.6× 226 1.3× 129 0.8× 16 0.2× 34 591
Hitoshi Takahashi Japan 12 147 0.5× 137 0.8× 163 0.9× 28 0.2× 17 0.2× 36 508
Cecilia Mancini Italy 17 46 0.2× 84 0.5× 421 2.4× 50 0.3× 100 1.3× 51 760

Countries citing papers authored by Prashant Mehta

Since Specialization
Citations

This map shows the geographic impact of Prashant Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Mehta more than expected).

Fields of papers citing papers by Prashant Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Mehta. The network helps show where Prashant Mehta may publish in the future.

Co-authorship network of co-authors of Prashant Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Mehta. A scholar is included among the top collaborators of Prashant Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Mehta. Prashant Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalra, Sanjay, Irfan Ahmed Shaikh, Nitin Kapoor, et al.. (2025). An Indian Consensus on Sarcopenia: Epidemiology, Etiology, Clinical Impact, Screening, and Therapeutic Approaches. International Journal of General Medicine. Volume 18. 1731–1745.
2.
Karam, Sabine, et al.. (2025). Acute Kidney Injury Associated with Novel Anticancer Therapies. Kidney360. 6(4). 652–662.
3.
Mehta, Prashant, Anuradha Choughule, Harsh Sheth, et al.. (2025). Uniform Reporting of Next Generation Sequencing: Indian Society of Medical and Pediatric Oncology. Indian Journal of Medical and Paediatric Oncology. 46(4). 351–362.
5.
Mehta, Prashant, et al.. (2023). Epidemiology and survival analysis of head and neck cancer: Results from comprehensive care center in North India. SHILAP Revista de lepidopterología. 6. 100022–100022. 10 indexed citations
6.
Mehta, Prashant, et al.. (2021). PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review. Advances in genetics. 108. 35–80. 7 indexed citations
7.
Talwar, Vineet, et al.. (2020). Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC). Frontiers in Oncology. 10. 964–964. 13 indexed citations
8.
Srivastava, Priyanka, Chandan Krushna Das, Bivas Biswas, et al.. (2020). Advisory for cancer patients during the COVIDpandemic. Cancer Research Statistics and Treatment. 3(5). 145–145. 15 indexed citations
9.
10.
Parikh, Purvish M., et al.. (2020). “Serious Adverse Events” Faced by Clinical Trials: Impact of the COVID-19 Pandemic. Indian Journal of Medical and Paediatric Oncology. 41(2). 127–131. 2 indexed citations
11.
Tannock, Ian F., Priyanka Srivastava, Bivas Biswas, et al.. (2020). Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. JCO Global Oncology. 6(6). 382–386. 22 indexed citations
12.
Mehta, Prashant, et al.. (2019). Personalized Medicine in Diffuse Large B-Cell Lymphoma. Indian Journal of Medical and Paediatric Oncology. 40(4). 463–464. 2 indexed citations
13.
Parikh, Purvish M., Prashant Mehta, Amit Verma, et al.. (2017). Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care. 2(2). 47–47. 2 indexed citations
14.
Gogia, Ajay, Prashant Mehta, Raja Pramanik, & Rajive Kumar. (2014). Isolated Breast Relapse Mimicking Breast Cancer in Elderly Patient with Acute Lymphoblastic Leukemia. Turkish Journal of Hematology. 31(2). 203–204. 1 indexed citations
15.
Gogia, Ajay, Prashant Mehta, Raja Pramanik, & Ritu Gupta. (2014). Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation. South Asian Journal of Cancer. 3(4). 235–236. 1 indexed citations
16.
Mehta, Prashant. (2011). EVALUATIVE TRENDS OF ILLICIT DRUGS USES IN INDIA AND ANALYSIS OF INDIAN AND INTERNATIONAL LAWS OF PROHIBITION OF DRUGS OF ABUSE. 1(1). 32–43. 1 indexed citations
17.
Raber, Jacob, et al.. (1997). Coloboma Hyperactive Mutant Mice Exhibit Regional and Transmitter‐Specific Deficits in Neurotransmission. Journal of Neurochemistry. 68(1). 176–186. 82 indexed citations
18.
Schiavo, Giampietro, Annalisa Santucci, Bibhuti R. DasGupta, et al.. (1993). Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bonds. FEBS Letters. 335(1). 99–103. 347 indexed citations
19.
Omkumar, R.V., Prashant Mehta, C. K. Ramakrishna Kurup, & T. Ramasarma. (1992). Preparation of a soluble 58kDa-3-hydroxy-3-methylglutaryl CoA reductase from liver microsomes and its inhibition by ethoxysilatrane, a hypocholesterolemic compound. Molecular and Cellular Biochemistry. 110(2). 145–153. 4 indexed citations
20.
Mehta, Prashant, T. Ramasarma, & C. K. Ramakrishna Kurup. (1987). Hypocholesterolemic action of 1-ethoxysilatrane. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 920(1). 102–104. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026